[go: up one dir, main page]

ZA969246B - Use of prostaglandin E1, E2 or analogs to prevent renal failure induced by medical tests that ulilize contrast media agents. - Google Patents

Use of prostaglandin E1, E2 or analogs to prevent renal failure induced by medical tests that ulilize contrast media agents.

Info

Publication number
ZA969246B
ZA969246B ZA9609246A ZA969246A ZA969246B ZA 969246 B ZA969246 B ZA 969246B ZA 9609246 A ZA9609246 A ZA 9609246A ZA 969246 A ZA969246 A ZA 969246A ZA 969246 B ZA969246 B ZA 969246B
Authority
ZA
South Africa
Prior art keywords
ulilize
prostaglandin
analogs
renal failure
contrast media
Prior art date
Application number
ZA9609246A
Inventor
Henry T Stratton
Tammy K Antonucci
Erwin Schollmayer
Original Assignee
Schwarz Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/563,392 external-priority patent/US5807895A/en
Application filed by Schwarz Pharma Inc filed Critical Schwarz Pharma Inc
Publication of ZA969246B publication Critical patent/ZA969246B/en

Links

ZA9609246A 1995-11-28 1996-11-04 Use of prostaglandin E1, E2 or analogs to prevent renal failure induced by medical tests that ulilize contrast media agents. ZA969246B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/563,392 US5807895A (en) 1994-11-29 1995-11-28 Use of prostaglandin E1, E2 or analogs to prevent renal failure induced by medical tests that utilize contrast media agents

Publications (1)

Publication Number Publication Date
ZA969246B true ZA969246B (en) 1998-05-04

Family

ID=24250311

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9609246A ZA969246B (en) 1995-11-28 1996-11-04 Use of prostaglandin E1, E2 or analogs to prevent renal failure induced by medical tests that ulilize contrast media agents.

Country Status (1)

Country Link
ZA (1) ZA969246B (en)

Similar Documents

Publication Publication Date Title
BG102200A (en) Transcorneal system for the release of a medicament
TR200000782T2 (en) Resorcinol derivatives.
DE69021887D1 (en) Control system for the hydraulic brake pressure.
JO1619B1 (en) Contrast media
AU4376396A (en) Use of andrographolide compounds to treat or prevent pathogenicity of diseases
NO881477L (en) CLUTCH, SPECIAL FOR MEDICAL USE.
NO159256C (en) OIL OIL FIGHTING VESSEL.
GR3032363T3 (en) Substituted cinnamic acid guanidides, process for their preparation, their use as cardiovascualr medicament or diagnostic agent, as well as medicament containing them
EP0142517A4 (en) 2-acylimidazole compounds, their synthesis and use as immunosuppresive medicinal agents.
DE69510545D1 (en) CCK OR GASTRINE MODULATING 5-HETEROCYCLICYL-1,5-BENZODIAZEPINE
ITMI913465A1 (en) PROCEDURE FOR THE PURIFICATION OF 1, 1, 1-TRIFLUORO-2-FLUOROETANO
MX9201136A (en) VISIBLE BRAKING BLOCK WEAR INDICATOR.
BR9812780A (en) 2-aryl-3-aroilbenzo [b] thiophenes useful for the treatment of estrogen loss syndrome
ES531338A0 (en) A PROCEDURE FOR THE PREPARATION OF NEW ANALOGS OF MYTHOMICINE.
ES515671A0 (en) "PROCEDURE FOR THE PREPARATION AND PURIFICATION OF 1,2-DICHLOROETHANE".
EP0682239A3 (en) Differential pressure transducer.
ZA969246B (en) Use of prostaglandin E1, E2 or analogs to prevent renal failure induced by medical tests that ulilize contrast media agents.
ES510135A0 (en) "PROCEDURE FOR THE PURIFICATION OF HEXAMETILDISILOXANO".
ES515331A0 (en) A PROCEDURE FOR THE PREPARATION OF TETRAZOLE DERIVATIVES.
ES514126A0 (en) "A PROCEDURE FOR THE PREPARATION OF A NEW BICYCLE COMPOUND".
NO883227L (en) PRESSURE FLUID CONTROL SYSTEM.
DE69106147D1 (en) Control device for hydraulic brake pressure.
ES510181A0 (en) "A PROCEDURE FOR THE PREPARATION OF 1- (1,3-BENDODIOXOL-5-IL) -2-PIRROLIDINONE".
BE899033A (en) NON-STEROIDIC ANTI-INFLAMMATORY DRUGS
MY124089A (en) Use of cetirizine for preventing the onset of asthma